Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-13-000053
Filing Date
2013-11-07
Accepted
2013-11-07 13:18:27
Documents
3
Period of Report
2013-11-07

Document Format Files

Seq Description Document Type Size
1 6-K - THIRD QUARTER 2013 PRESS RELEASE thirdquarter2013pressrelea.htm 6-K 20027
2 THIRD QUARTER 2013 PRESS RELEASE ex991pressreleaseq32013.htm EX-99.1 173367
3 LOGO finalonclogo.jpg GRAPHIC 32654
  Complete submission text file 0001129928-13-000053.txt   239540
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 131199699
SIC: 2834 Pharmaceutical Preparations